Harrow (HROW) News Today $36.10 +2.25 (+6.65%) Closing price 04:00 PM EasternExtended Trading$35.08 -1.02 (-2.83%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW)Brookstone Capital Management bought a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 8,188 shares of the company's stock, valued at approximately $275,000. OtheJanuary 19 at 3:11 AM | marketbeat.comHarrow (NASDAQ:HROW) Stock Price Down 4.1% - Should You Sell?Harrow (NASDAQ:HROW) Shares Down 4.1% - Here's What HappenedJanuary 16, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 194,480 Shares of Harrow, Inc. (NASDAQ:HROW)JPMorgan Chase & Co. grew its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 443.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 238,367 shares of the company's stock after acquiring an additional 194,480 shJanuary 13, 2025 | marketbeat.comHarrow announces Amir Shojaei, PharmD, PhD joins as CSOJanuary 8, 2025 | markets.businessinsider.comHarrow Health (HROW) Gets a Buy from Craig-HallumJanuary 8, 2025 | markets.businessinsider.comHarrow Appoints Amir H. Shojaei as Chief Scientific OfficerJanuary 7, 2025 | finance.yahoo.comThose Derisked Baby Bonds Of Harrow, Inc.January 3, 2025 | seekingalpha.comHarrow (NASDAQ:HROW) Stock Price Up 7.7% - Still a Buy?Harrow (NASDAQ:HROW) Trading 7.7% Higher - Time to Buy?January 2, 2025 | marketbeat.comFranklin Resources Inc. Has $576,000 Holdings in Harrow, Inc. (NASDAQ:HROW)Franklin Resources Inc. trimmed its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 94.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,817 shares of the company's stock after selling 229,628 shares during thDecember 31, 2024 | marketbeat.comBarclays PLC Buys 39,506 Shares of Harrow, Inc. (NASDAQ:HROW)Barclays PLC lifted its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 301.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,593 shares of the company's stock after acquiring an additional 39,50December 26, 2024 | marketbeat.comHarrow (NASDAQ:HROW) Trading Down 2.5% - Should You Sell?Harrow (NASDAQ:HROW) Trading Down 2.5% - Here's What HappenedDecember 24, 2024 | marketbeat.comState Street Corp Raises Stake in Harrow, Inc. (NASDAQ:HROW)State Street Corp raised its holdings in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 2.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 730,973 shares of the company's stock after purchasing an additiDecember 22, 2024 | marketbeat.comHarrow's Valuation Hinges On Lofty Growth Amid Persistent Financial StrainsDecember 18, 2024 | seekingalpha.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $1.47 Million in Harrow, Inc. (NASDAQ:HROW)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 32,678 sDecember 17, 2024 | marketbeat.comHarrow: The Triesence RelaunchDecember 14, 2024 | seekingalpha.comWestside Investment Management Inc. Cuts Position in Harrow, Inc. (NASDAQ:HROW)Westside Investment Management Inc. lowered its stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 21.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 165,944 shares of theDecember 12, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Sold by Stifel Financial CorpStifel Financial Corp lowered its stake in Harrow, Inc. (NASDAQ:HROW - Free Report) by 25.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 407,264 shares of the company's stock after selling 135,583 shares duringDecember 10, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Holdings in Harrow, Inc. (NASDAQ:HROW)Charles Schwab Investment Management Inc. boosted its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 195.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 251,629 shares ofDecember 10, 2024 | marketbeat.comVerition Fund Management LLC Invests $951,000 in Harrow, Inc. (NASDAQ:HROW)Verition Fund Management LLC bought a new stake in Harrow, Inc. (NASDAQ:HROW - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 21,147 shares of the company's stock, valued at approximateDecember 9, 2024 | marketbeat.comB. Riley Estimates Harrow's FY2024 Earnings (NASDAQ:HROW)Harrow, Inc. (NASDAQ:HROW - Free Report) - Research analysts at B. Riley dropped their FY2024 earnings per share (EPS) estimates for Harrow in a research report issued on Wednesday, December 4th. B. Riley analyst M. Mamtani now forecasts that the company will earn ($0.53) per share for the year,December 6, 2024 | marketbeat.comBNP Paribas Financial Markets Acquires 77,407 Shares of Harrow, Inc. (NASDAQ:HROW)BNP Paribas Financial Markets increased its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 3,015.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,974 shares of the company'December 5, 2024 | marketbeat.comQuantbot Technologies LP Acquires New Stake in Harrow, Inc. (NASDAQ:HROW)Quantbot Technologies LP bought a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 12,218 shares of the company's stock, valued at approximately $549,000. SeveraDecember 3, 2024 | marketbeat.comBraidwell LP Has $19.77 Million Stock Holdings in Harrow, Inc. (NASDAQ:HROW)Braidwell LP grew its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 47.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 439,638 shares of the company's stock after buying an additional 142,450 shares durinNovember 29, 2024 | marketbeat.comBBR Partners LLC Grows Stock Position in Harrow, Inc. (NASDAQ:HROW)BBR Partners LLC increased its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 181.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,000 shares of the company's stock after buying an additionalNovember 28, 2024 | marketbeat.com44,180 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Penserra Capital Management LLCPenserra Capital Management LLC bought a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 44,180 shares of the company's stock, valued at approximately $1,986,000. Penserra CaNovember 26, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Invests $5.86 Million in Harrow, Inc. (NASDAQ:HROW)Connor Clark & Lunn Investment Management Ltd. bought a new stake in Harrow, Inc. (NASDAQ:HROW - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 130,424 shares of the company's stock, vNovember 23, 2024 | marketbeat.comHarrow's Unit Wins Trademark Infringement Case Against OSRXNovember 21, 2024 | markets.businessinsider.comHarrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.November 21, 2024 | finance.yahoo.comHarrow unit gets $34.9M in jury verdict in case of ImprimisRx v. OSRXNovember 21, 2024 | markets.businessinsider.comFormer Harrow unit Melt announces results for MELT-300 to sedate for surgeryNovember 21, 2024 | markets.businessinsider.comFirst Turn Management LLC Makes New Investment in Harrow, Inc. (NASDAQ:HROW)First Turn Management LLC acquired a new position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 326,582 shares of the company's stock, valued at approximately $14,683,000. Harrow accounts for 2.November 19, 2024 | marketbeat.comOppenheimer & Co. Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW)Oppenheimer & Co. Inc. bought a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 28,177 shares of the company's stock, valued at approximately $1,267,000. Oppenheimer & Co. Inc. owned approximatNovember 19, 2024 | marketbeat.comHarrow Health’s Strategic Transformation and Growth Potential Underscore Buy RatingNovember 18, 2024 | markets.businessinsider.comHarrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LPRoyce & Associates LP decreased its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 33.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 360,320 shares of the company's stock after selling 179,580 shares during theNovember 16, 2024 | marketbeat.comHarrow: Spotlight On IHEEZONovember 16, 2024 | seekingalpha.comHarrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...November 15, 2024 | finance.yahoo.comHarrow (NASDAQ:HROW) Shares Down 7.3% - Here's WhyHarrow (NASDAQ:HROW) Shares Down 7.3% - What's Next?November 15, 2024 | marketbeat.comHarrow Inc. Reports Strong Q3 2024 GrowthNovember 15, 2024 | markets.businessinsider.comHarrow Health: Strong Growth Prospects Amid Market OverreactionNovember 15, 2024 | markets.businessinsider.comHarrow, Inc. (HROW) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comHarrow, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 14, 2024 | seekingalpha.comHarrow (NASDAQ:HROW) Shares Gap Down - Here's WhyHarrow (NASDAQ:HROW) Shares Gap Down - Time to Sell?November 14, 2024 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Sold by Los Angeles Capital Management LLCLos Angeles Capital Management LLC lowered its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 47.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 43,109 shares of the company's stock after selling 38,168 sharesNovember 14, 2024 | marketbeat.comHarrow Health options imply 15.2% move in share price post-earningsNovember 13, 2024 | markets.businessinsider.comHarrow Launches Access and Affordability Program with Price Reductions for Branded ProductsNovember 13, 2024 | finance.yahoo.comHarrow stock plunges 20% on weaker-than-expected Q3 earningsNovember 13, 2024 | msn.comHarrow Announces Third Quarter 2024 Financial ResultsNovember 13, 2024 | businesswire.comEarnings Outlook For HarrowNovember 12, 2024 | benzinga.comHarrow Announces Market Access Wins for VEVYE®November 12, 2024 | finance.yahoo.comCraig-Hallum Sticks to Their Buy Rating for Harrow Health (HROW)November 11, 2024 | markets.businessinsider.com Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address HROW Media Mentions By Week HROW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼1.200.57▲Average Medical News Sentiment HROW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼23▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News TG Therapeutics News Axsome Therapeutics News Verona Pharma News Organon & Co. News Prestige Consumer Healthcare News Biohaven News Apellis Pharmaceuticals News Ultragenyx Pharmaceutical News Viking Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harrow With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
